These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16496669)

  • 21. Design and Characterization of Agarose/HPMC Buccal Films Bearing Ondansetron HCl In Vitro and In Vivo: Enhancement Using Iontophoretic and Chemical Approaches.
    Jillani U; Mudassir J; Ijaz QA; Latif S; Qamar N; Aleem A; Ali E; Abbas K; Wazir MA; Hussain A; Abbas N; Arshad MS
    Biomed Res Int; 2022; 2022():1662194. PubMed ID: 35372569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel two-step release system for the traditional Chinese medicine compound Danshen.
    Li Y; Hou S; Bi Y; Zheng Y; Cai Z; Cheng Q; Song X
    Yakugaku Zasshi; 2007 Sep; 127(9):1473-84. PubMed ID: 17827927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of controlled release osmotic pump tablet of glipizide solid dispersion.
    Patel GC; Asodaria KV; Patel HP; Shah DR
    Curr Drug Deliv; 2014; 11(6):817-27. PubMed ID: 23859357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and evaluation of an osmotic pump tablet (OPT) for prednisolone, a poorly water soluble drug, using (SBE)7m-beta-CD.
    Okimoto K; Miyake M; Ohnishi N; Rajewski RA; Stella VJ; Irie T; Uekama K
    Pharm Res; 1998 Oct; 15(10):1562-8. PubMed ID: 9794499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors affecting membrane-controlled drug release for an osmotic pump tablet (OPT) utilizing (SBE)(7m)-beta-CD as both a solubilizer and osmotic agent.
    Okimoto K; Ohike A; Ibuki R; Aoki O; Ohnishi N; Rajewski RA; Stella VJ; Irie T; Uekama K
    J Control Release; 1999 Aug; 60(2-3):311-9. PubMed ID: 10425336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study of sustained-matrix tablets Ambroxol hydrochloride and potential impact of different fillers on the matrix tablet's scale-up].
    Wang MY; Yang YP; Chang JB; Guo MT
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):742-8. PubMed ID: 23073585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucoadhesive elementary osmotic pump tablets of trimetazidine for controlled drug delivery and reduced variability in oral bioavailability.
    Alam N; Beg S; Rizwan M; Ahmad A; Ahmad FJ; Ali A; Aqil M
    Drug Dev Ind Pharm; 2015 Apr; 41(4):692-702. PubMed ID: 24669975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
    Rujivipat S; Bodmeier R
    Int J Pharm; 2010 Dec; 402(1-2):72-7. PubMed ID: 20883759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation and development of pH-independent/dependent sustained release matrix tablets of ondansetron HCl by a continuous twin-screw melt granulation process.
    Patil H; Tiwari RV; Upadhye SB; Vladyka RS; Repka MA
    Int J Pharm; 2015 Dec; 496(1):33-41. PubMed ID: 25863118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation of monolithic osmotic pump system by coating the indented core tablet.
    Liu L; Che B
    Eur J Pharm Biopharm; 2006 Oct; 64(2):180-4. PubMed ID: 16797951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microporous bilayer osmotic tablet for colon-specific delivery.
    Chaudhary A; Tiwari N; Jain V; Singh R
    Eur J Pharm Biopharm; 2011 May; 78(1):134-40. PubMed ID: 21255646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel pulsed-release system based on swelling and osmotic pumping mechanism.
    Zhang Y; Zhang Z; Wu F
    J Control Release; 2003 Apr; 89(1):47-55. PubMed ID: 12695062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of different plasticizers on some physical and mechanical properties of hydroxypropyl methylcellulose free films.
    Saringat HB; Alfadol KI; Khan GM
    Pak J Pharm Sci; 2005 Jul; 18(3):25-38. PubMed ID: 16380341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preparation of buspirone hydrochloride buccal adhesive tablet and study on its drug release mechanism].
    Du Q; Ping QN; Liu GJ
    Yao Xue Xue Bao; 2002 Aug; 37(8):653-6. PubMed ID: 12567784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanistic investigation of drug release from asymmetric membrane tablets: effect of media gradients (osmotic pressure and concentration), and potential coating failures on in vitro release.
    Am Ende MT; Miller LA
    Pharm Res; 2007 Feb; 24(2):288-97. PubMed ID: 17180730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and evaluation of buccal bioadhesive tablet of an anti-emetic agent ondansetron.
    Hassan N; Khar RK; Ali M; Ali J
    AAPS PharmSciTech; 2009; 10(4):1085-92. PubMed ID: 19757080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled release of metformin hydrochloride and repaglinide from sandwiched osmotic pump tablet.
    Qin C; He W; Zhu C; Wu M; Jin Z; Zhang Q; Wang G; Yin L
    Int J Pharm; 2014 May; 466(1-2):276-85. PubMed ID: 24607209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and optimization of buspirone oral osmotic pump tablet.
    Derakhshandeh K; Berenji MG
    Res Pharm Sci; 2014; 9(4):233-41. PubMed ID: 25657794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preperation of terbutaline sulphate pulsatile release tablet and mechanism elucidation].
    Zhang Y; Zhang ZR
    Yao Xue Xue Bao; 2003 Nov; 38(11):854-8. PubMed ID: 14992001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and
    Li N; Fan L; Wu B; Dai G; Jiang C; Guo Y; Wang D
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1079-1088. PubMed ID: 30909753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.